| Literature DB >> 27075628 |
Vicent Ribas1, Brian G Drew1, Zhenqi Zhou1, Jennifer Phun1, Nareg Y Kalajian1, Teo Soleymani1, Pedram Daraei1, Kevin Widjaja1, Jonathan Wanagat2, Thomas Q de Aguiar Vallim3, Amy H Fluitt4, Steven Bensinger5, Thuc Le6, Caius Radu6, Julian P Whitelegge7, Simon W Beaven8, Peter Tontonoz8, Aldons J Lusis9, Brian W Parks10, Laurent Vergnes10, Karen Reue10, Harpreet Singh11, Jean C Bopassa11, Ligia Toro11, Enrico Stefani11, Matthew J Watt12, Simon Schenk13, Thorbjorn Akerstrom14, Meghan Kelly14, Bente K Pedersen14, Sylvia C Hewitt15, Kenneth S Korach15, Andrea L Hevener16.
Abstract
Impaired estrogen receptor α (ERα) action promotes obesity and metabolic dysfunction in humans and mice; however, the mechanisms underlying these phenotypes remain unknown. Considering that skeletal muscle is a primary tissue responsible for glucose disposal and oxidative metabolism, we established that reduced ERα expression in muscle is associated with glucose intolerance and adiposity in women and female mice. To test this relationship, we generated muscle-specific ERα knockout (MERKO) mice. Impaired glucose homeostasis and increased adiposity were paralleled by diminished muscle oxidative metabolism and bioactive lipid accumulation in MERKO mice. Aberrant mitochondrial morphology, overproduction of reactive oxygen species, and impairment in basal and stress-induced mitochondrial fission dynamics, driven by imbalanced protein kinase A-regulator of calcineurin 1-calcineurin signaling through dynamin-related protein 1, tracked with reduced oxidative metabolism in MERKO muscle. Although muscle mitochondrial DNA (mtDNA) abundance was similar between the genotypes, ERα deficiency diminished mtDNA turnover by a balanced reduction in mtDNA replication and degradation. Our findings indicate the retention of dysfunctional mitochondria in MERKO muscle and implicate ERα in the preservation of mitochondrial health and insulin sensitivity as a defense against metabolic disease in women.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27075628 PMCID: PMC4934679 DOI: 10.1126/scitranslmed.aad3815
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956